Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-04-23 @ 8:41 PM
Study NCT ID:
NCT01985334
Status:
COMPLETED
Last Update Posted:
2019-03-19
First Post:
2013-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-04
First Submit QC Date:
None
Study First Post Date:
2013-11-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-05
Results First Submit QC Date:
None
Results First Post Date:
2019-03-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-18
Last Update Post Date:
2019-03-19
Last Update Post Date Type:
ACTUAL